All Articles

Duff & Phelps' utility fund is raising dividends and buying back shares. We break down if this is a sustainable strategy or a short-term sugar rush.

Adaptive Biotechnologies' new debt offering is more than a financial tune-up; it's a calculated move to sever a costly royalty deal and arm its star MRD division for a separate future.

Facing delisting, J-Star Holding bets its 50-year legacy and a high-stakes battery venture against the unforgiving mechanics of the public market.

Icelandic biotech Alvotech seeks $125M in a complex dual offering to advance its low-cost drug pipeline, but regulatory hurdles and financial pressures loom.

Verastem Oncology is preparing to show its hand with VS-7375, a novel dual-action KRAS G12D inhibitor. Can its unique science disrupt a crowded market?

e.l.f. Beauty, a titan of viral cosmetics, is entering the haircare chat. This is more than a new product; it's a test of its disruptive model.

L'Oréal Canada's latest buyout via its SalonCentric arm solidifies its Quebec market power, signaling a major strategic shift for stylists and competitors.

Marwest REIT's modest 2.1% distribution increase reveals deep financial stability in Western Canada's rental market, a stark contrast to national trends.

Beyond a simple dividend, BSR REIT's latest distribution reveals a strategy rooted in Sunbelt growth and financial discipline. Here's a deep dive.

Beyond simple expansion, Bull Moose Tube's acquisition of Hanna Steel is a strategic masterstroke in vertical integration, aiming to dominate the steel tube market.

Showpass's acquisition of Bounce isn't just about tickets. It's a calculated move to unify a fragmented market and tackle the student loneliness crisis.

Crystal Bayliss takes the helm at the U.S. Plastics Pact, bringing a supply chain veteran's pragmatism to the immense challenge of plastics circularity.

HPE's new quantum strategy isn't just about qubits; it's about building a resilient bridge between classical HPC and the quantum future.

A new AI tool is shifting post-acute care from relationship-based referrals to data-driven strategy by analyzing entire physician groups, not just doctors.

In a digital world, the physical print is a statement. A deep dive into the craft, guided by expert Henry McCoy, reveals why materials and process matter.

AIRA ushers in new leadership with Boris Steffen as President, poised to navigate economic turbulence and shape the future of the insolvency profession.

A new company is skipping the AI hype of replacing lawyers. Its secure, voice-first platform targets the administrative slog that fuels burnout and drains profits.

A new platform, SmartFocus.ai, offers AI-powered focus groups for $99. We explore if this democratizes research or if synthetic audiences miss human truth.

A new global conference, IMPAKT, launches in London, promising real outcomes over AI buzz. But in a crowded field, can it truly reshape executive discourse?

The sports betting ETF is ditching its passive index. This strategic pivot is more than a fund management change; it’s a bet on active management.